Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymorphic differences in drug metabolism and response.

S J Vetticaden1

  • 1Biopharmaceutics Research Enterprise, Ltd., Rockville, MD.

Methods and Findings in Experimental and Clinical Pharmacology
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatography of cardiac glycosides.

Journal of chromatography·1990
Same author

Pharmacodynamic modeling of digoxin-induced bradycardia.

Journal of pharmacokinetics and biopharmaceutics·1989
Same author

Phenotypic differences in dextromethorphan metabolism.

Pharmaceutical research·1989
Same author

Improved method for assaying digoxin in serum using high-performance liquid chromatography-radioimmunoassay.

Journal of chromatography·1986
Same author

Digoxin absorption in a patient with short-bowel syndrome.

Clinical pharmacy·1986
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

Genetic variations cause differences in drug metabolism and response, impacting drug effectiveness and safety. Understanding these pharmacogenetic differences is crucial for personalized medicine and avoiding adverse drug reactions.

Area of Science:

  • Pharmacogenetics
  • Drug Metabolism
  • Genomics

Background:

  • Genetic variations lead to pharmacogenetic differences, affecting drug pharmacokinetics and pharmacodynamics.
  • Polymorphisms in drug metabolism, such as acetylation and debrisoquin oxidation, have been geographically studied.
  • Cytochrome P-450 variants are linked to observed drug metabolism polymorphisms.

Purpose of the Study:

  • To highlight the clinical significance of recognizing polymorphic differences in drug disposition.
  • To emphasize the importance of understanding genetic influences on drug metabolism for therapeutic success.
  • To recommend methods for investigating anomalous drug metabolism and response.

Main Methods:

  • Extensive investigation of acetylation and debrisoquin oxidation to map geographical distribution of metabolic polymorphisms.

Related Experiment Videos

  • Correlation of various drug metabolic pathways with debrisoquin metabolism.
  • Utilizing innocuous probes like dextromethorphan or antipyrine for investigating anomalous drug metabolism.

    • Main Results:

    • Polymorphisms in drug metabolism are attributed to cytochrome P-450 variants.
    • Metabolic pathway deficiencies increase susceptibility to adverse drug reactions.
    • Genetic polymorphism in drug metabolism influences therapeutic outcomes, especially in diverse ethnic populations.

    Conclusions:

    • Medical recognition of pharmacogenetic differences is vital for patient safety and effective treatment.
    • Understanding genetic polymorphism in drug metabolism is essential for personalized medicine.
    • Investigating drug metabolism using low-dose probes can help identify and manage metabolic variations.